A lipid-lowering agent belonging to the statin class. It works by inhibiting HMG-CoA reductase, the key enzyme in cholesterol biosynthesis, thereby reducing total cholesterol, LDL-C, and triglycerides while increasing HDL-C. Used primarily in the prevention and treatment of cardiovascular disease associated with hyperlipidemia.Indications:- Primary hypercholesterolemia (elevated LDL-C).- Mixed dyslipidemia (elevated LDL-C and triglycerides).- Secondary prevention of major cardiovascular events in patients with coronary heart disease.- Slowing progression of atherosclerosis.- Reduction of total cholesterol and LDL-C in pediatric patients (1016 years) with heterozygous familial hypercholesterolemia.Main Active Ingredient:- Fluvastatin sodium 80 mg (extended-release tablet).Precautions:- Contraindicated in patients with active liver disease or unexplained persistent elevations of liver transaminases.- Contraindicated in pregnancy and breastfeeding.- Use with caution in patients with renal impairment or history of alcohol abuse.- Monitor liver function tests before initiation and periodically during therapy.- Risk of myopathy and rhabdomyolysis increases with higher doses and in elderly patients.- Discontinue immediately if unexplained muscle pain, weakness, or dark urine occurs.- Not established for use in children <10 years of age.Side Effects:- Headache.- Dizziness.- Fatigue.- Nausea.- Dyspepsia.- Diarrhea.- Constipation.- Elevated liver enzymes.- Abdominal pain.- Rash.- Insomnia.- Myopathy.- Rhabdomyolysis.- Hepatitis.- Jaundice.- Angioedema.- Anaphylaxis.Drug-Drug Interactions:- Increased risk of myopathy with: Ciclosporin, fibrates, niacin, colchicine.- CYP2C9 inhibitors.- Warfarin.- Rifampicin and phenytoin.

- Usual adult dose: One 80 mg extended-release tablet once daily.- Take in the evening or at bedtime, with or without food.- Swallow whole; do not crush or chew.- Continue with a cholesterol-lowering diet during treatment.- Dosage adjustment may be required in patients with hepatic or renal impairment.- Long-term therapy is often necessary to maintain lipid control.

• Anti-hyperlipidemic

Fluvastatin sodium,Hydroxypropyl cellulose,Hypromellose,Magnesium stearate,Microcrystalline cellulose,Povidone,Sodium stearyl fumarate,Talc,Titanium dioxide,Iron oxides.